Vector-gene combination is used in the latest clinical trial of gene therapy as a possible tool to provide long-term relief from disabling bleeds. Investigators report no evidence of toxicity in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback